Qiang An

Dr. Qiang An

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2018 in Bioresource Technology
Verified
Journal Article
Closed access
BZBin Zhao
Bin Zhao
DCDan Yang Cheng
Dan Yang Cheng
PTPan Tan
Pan Tan
QAQiang An
Qiang An
JGJin Song Guo
Jin Song Guo

1 February 2020 in Bioresource Technology
Verified
Journal Article
Closed access
YYYang Yu
Yang Yu
QAQiang An
Qiang An
LJLin Jin
Lin Jin
NLNing Luo
Ning Luo
ZLZheng Li
Zheng Li
JJJunnan Jiang
Junnan Jiang

1 January 2019 in Chemosphere
Verified
Journal Article
Closed access
QAQiang An
Qiang An
YJYun-Qiu Jiang
Yun-Qiu Jiang
HNHong-Yan Nan
Hong-Yan Nan
YYYang Yu
Yang Yu
JJJun-Nan Jiang
Jun-Nan Jiang

11 October 2019 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
JBJ.E. Baron
J.E. Baron
ASA.G. Shamrock
A.G. Shamrock
WCW.T. Cates
W.T. Cates
RCR.A. Cates
R.A. Cates
QAQiang An
Qiang An
RWR.W. Westermann
R.W. Westermann
Background: Reported infection rates following anterior cruciate ligament (ACL) reconstruction are low, but infections are associated with high morbidity including reoperations and inferior clinical outcomes. The purpose of the current study was to investigate the rate of infection after ACL reconstruction with and without graft preparation with a vancomycin irrigant. Methods: All ACL reconstructions performed between May 2009 and August 2018 at a single academic institution were reviewed and categorized based on vancomycin use. Patients with <90-day follow-up, intraoperative graft preparation with an antibiotic other than vancomycin, or previous ipsilateral knee infection were excluded. Infection was defined as a return to the operating room for irrigation and debridement within 90 days after ACL reconstruction. Descriptive and inferential statistical analysis using t tests and Poisson regression were performed, with significance defined as p < 0.05. Results: In total, 1,640 patients (952 males; 58.0%) with a mean age (and standard deviation) of 27.7 ± 11.4 years underwent ACL reconstruction (1,379 primary procedures; 84.1%) and were included for analysis. Intraoperative vancomycin was used in 798 cases (48.7%), whereas 842 ACL reconstructions (51.3%) were performed without intraoperative vancomycin. In total, 11 reconstructions (0.7%) were followed by infection, which occurred in 10 (1.2%) of the patients in whom the graft was not soaked in vancomycin and in 1 (0.1%) of the patients in whom the graft was soaked in vancomycin (p = 0.032). Age (p = 0.571), sex (p = 0.707), smoking (p = 0.407), surgeon (p = 0.124), and insurance type (p = 0.616) were not associated with postoperative infection risk. Autograft use was associated with decreased infections (p = 0.045). There was an 89.4% relative risk reduction with the use of intraoperative vancomycin. An increased body mass index (BMI) (p = 0.029), increased operative time (p = 0.001), and the absence of ACL graft preparation with vancomycin (p = 0.032) independently predicted postoperative infection. Conclusions: The use of vancomycin-soaked grafts was associated with a 10-fold reduction in infection after ACL reconstruction (0.1% versus 1.2%; p = 0.032). Other risk factors for infection after ACL reconstruction included increased BMI and increased operative time. Level of Evidence: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

1 February 2017 in Bioresource Technology
Verified
Journal Article
Closed access
BZBin Zhao
Bin Zhao
MTMeng Tian
Meng Tian
QAQiang An
Qiang An
JYJun Ye
Jun Ye
JGJin Song Guo
Jin Song Guo

1 May 2019 in Bioresource Technology
Verified
Journal Article
Closed access
YYYang Yu
Yang Yu
QAQiang An
Qiang An
YZYing Zhou
Ying Zhou
SDShuman Deng
Shuman Deng
YMYue Miao
Yue Miao
LYLi Yang
Li Yang